Increased use of melatonin for sleep problems in children is one surprising finding of a health survey, reports Reuters Health.
In Australia, after research showing 60% of callers to cancer support line "13 11 20" reported insomnia symptoms, the Cancer Council Queensland has urged cancer patients and caregivers suffering from insomnia to seek help.
In the United Arab Emirates, insurance often doesn’t cover sleep disorders, while at a government hospital, the waiting period to register is nine months, reports Khaleej Times.
A sleep disorder makes Jodie believe her dreams are real, but it’s her other half who really suffers, reports The Daily Mail.
A connection between persistent insomnia and increased inflammation and mortality has been identified by a group of researchers from the University of Arizona. Their study, published in The American Journal of Medicine, found that people who suffer from persistent insomnia are at greater risk than those who experience intermittent insomnia.
Sense, a consumer sleep tracker that became one of Kickstarter's most funded products of all time, is now available to the public with new orders expected to ship this month, as reported by The Verge.
A WBALTV.com news report examines the increasing phenomena of sleep texting.
Zzoma is an FDA-cleared medical device designed by physicians at Sleep Specialists, LLC, as a positional therapy for obstructive sleep apnea (OSA).
People who sleep for more than 8 hours a day have an increased risk of stroke, according to a study by the University of Cambridge—and this risk doubles for older people who persistently sleep longer than average.
Might living a structured life with regularly established mealtimes and early bedtimes lead to a better life and perhaps even prevent the onset of mental illness?
In its 15th year, the conference boasts three keynote addresses, a bustling exhibit hall, and entertainment ranging from a full-fledged comedy show to impersonators and caricature artists.
Airweave, a premium bedding topper and pillow brand in Japan, is arriving in the United States with the opening of its flagship retail location on 498 Broome Street in the SoHo district of Manhattan, NY. It opens to the public on February 27, 2015.
A new treatment may bring hope for people who suffer from muscle cramps or spasms from neuromuscular disorders, diseases such as multiple sclerosis, or simply from nighttime leg cramps that keep people from sleeping.
Sleep researchers at the University of Adelaide are warning doctors and parents not to provide the drug melatonin to children to help control their sleep problems.
MedicalResearch.com interviews Matthew Buman, PhD, assistant professor, SNHP Exercise & Wellness, at Arizona State University on a study about lack of physical activity and sleep problems.
KPRC Houston discusses "learned" insomnia, the idea that some patients tell themselves they have better things to do than sleep.
Even is sleep tracker Sense worked perfectly, a writer for The New York Times says he's not sure that many people need one.
"2014 was a transformational year for Vanda with the Hetlioz launch in the US for the treatment of Non-24-Hour Sleep-Wake Disorder. We are impressed with the continued growth of HETLIOZ and are fortunate to be able to offer this important treatment option for patients," says Vanda Pharmaceuticals' president and CEO Mihael H. Polymeropoulos, MD, in a release about the company's fourth quarter 2014 and full year 2014 financial results.
In January, the Federal Motor Carrier Safety Administration issued a bulletin to medical examiners and training organizations regarding obstructive sleep apnea. A sleep physician with commercial transportation expertise weighs in.
On February 4, the US Food and Drug Administration approved the “SOMNOtouch RESP” by SOMNOmedics for use in sleep-disordered breathing diagnostics.